Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
3(75%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%
Ph phase_4
1
25%
Ph phase_2
1
25%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

4

all time

Status Distribution
Active(3)
Completed(1)

Detailed Status

Recruiting3
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)

Trials by Status

completed125%
recruiting375%

Recent Activity

3 active trials
Showing 4 of 4
recruitingnot_applicable

Efficacy of Investigator Product for the Amelioration of Digital Eye Strain in Children

NCT06589128
recruitingnot_applicable

Can Astaxanthin Help Manage Asthma in POlluted Areas?

NCT07507682
completedphase_2

Effect of Astaxanthin in Moderate to Severe Knee Osteoarthritis

NCT05437601
recruitingphase_4

Study of the Efficacy and Safety of Antioxidants Astaxanthin as an Adjuvant Therapy for Community Acquired Pneumonia Patients.

NCT06334874

Clinical Trials (4)

Showing 4 of 4 trials
NCT06589128Not Applicable

Efficacy of Investigator Product for the Amelioration of Digital Eye Strain in Children

Recruiting
NCT07507682Not Applicable

Can Astaxanthin Help Manage Asthma in POlluted Areas?

Recruiting
NCT05437601Phase 2

Effect of Astaxanthin in Moderate to Severe Knee Osteoarthritis

Completed
NCT06334874Phase 4

Study of the Efficacy and Safety of Antioxidants Astaxanthin as an Adjuvant Therapy for Community Acquired Pneumonia Patients.

Recruiting

All 4 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
4